Hester Biosciences

Hester Biosciences

HESTERBIO.NS
Ahmedabad, India· Est.

Hester Biosciences is a key player in the Indian animal health market, dedicated to improving livestock and poultry productivity through preventive healthcare solutions. The company has a diversified portfolio of live and inactivated vaccines, nutritional supplements, and therapeutics, with a strong manufacturing footprint and distribution network across India and select international markets. As a publicly listed entity, it focuses on expanding its product pipeline, enhancing manufacturing capacities, and exploring strategic partnerships to solidify its market position and drive sustainable growth.

HESTERBIO.NS · Stock Price

INR 1,370.30+35.95 (+2.69%)
Market Cap: $125.1M

Historical price data

AI Company Overview

Hester Biosciences is a key player in the Indian animal health market, dedicated to improving livestock and poultry productivity through preventive healthcare solutions. The company has a diversified portfolio of live and inactivated vaccines, nutritional supplements, and therapeutics, with a strong manufacturing footprint and distribution network across India and select international markets. As a publicly listed entity, it focuses on expanding its product pipeline, enhancing manufacturing capacities, and exploring strategic partnerships to solidify its market position and drive sustainable growth.

Animal HealthVeterinaryLivestockPoultry

Technology Platform

Utilizes fermentation and cell culture technology for the production of live and inactivated vaccines for livestock and poultry diseases.

Funding History

1
IPOUndisclosed

Opportunities

Growth is driven by rising protein consumption in India, government animal health programs, and export potential to similar emerging markets.
Expansion into new vaccine segments and leveraging increased manufacturing capacity are key near-term opportunities.

Risk Factors

Key risks include regulatory compliance in biological manufacturing, revenue volatility linked to disease outbreaks and tender cycles, intense competition from multinational and domestic firms, and dependence on raw material supply and cost.

Competitive Landscape

Competes with multinational animal health giants (Zoetis, Merck) and strong domestic players (Indian Immunologicals, Venky's). Differentiation is achieved through cost-effective manufacturing, a broad portfolio tailored to local diseases, and an extensive distribution network in India.